BIOMAT Database Logo BIOMAT Database Logo

An antitumor promoter from Moringa oleifera Lam. 1999

A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Institute of Chemistry, College of Science, University of the Philippines, Diliman, Quezon City, Philippines.

In the course of studies on the isolation of bioactive compounds from Philippine plants, the seeds of Moringa oleifera Lam. were examined and from the ethanol extract were isolated the new O-ethyl-4-(alpha-L-rhamnosyloxy)benzyl carbamate (1) together with seven known compounds, 4(alpha-L-rhamnosyloxy)-benzyl isothiocyanate (2), niazimicin (3), niazirin (4), beta-sitosterol (5), glycerol-1-(9-octadecanoate) (6), 3-O-(6'-O-oleoyl-beta-D-glucopyranosyl)-beta-sitosterol (7), and beta-sitosterol-3-O-beta-D-glucopyranoside (8). Four of the isolates (2, 3, 7, and 8), which were obtained in relatively good yields, were tested for their potential antitumor promoting activity using an in vitro assay which tested their inhibitory effects on Epstein-Barr virus-early antigen (EBV-EA) activation in Raji cells induced by the tumor promoter, 12-O-tetradecanoyl-phorbol-13-acetate (TPA). All the tested compounds showed inhibitory activity against EBV-EA activation, with compounds 2, 3 and 8 having shown very significant activities. Based on the in vitro results, niazimicin (3) was further subjected to in vivo test and found to have potent antitumor promoting activity in the two-stage carcinogenesis in mouse skin using 7,12-dimethylbenz(a)anthracene (DMBA) as initiator and TPA as tumor promoter. From these results, niazimicin (3) is proposed to be a potent chemo-preventive agent in chemical carcinogenesis.

UI MeSH Term Description Entries
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D006027 Glycosides Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside (glucose), pentoside (pentose), fructoside (fructose), etc. Upon hydrolysis, a sugar and nonsugar component (aglycone) are formed. (From Dorland, 28th ed; From Miall's Dictionary of Chemistry, 5th ed) Glycoside
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.

Related Publications

A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Antileishmanial compounds from Moringa oleifera Lam.
January 2014, Zeitschrift fur Naturforschung. C, Journal of biosciences,
A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Moringa oleifera Lam: Targeting Chemoprevention.
January 2016, Asian Pacific journal of cancer prevention : APJCP,
A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Studies on peroxidase from Moringa oleifera Lam leaves.
January 2021, Heliyon,
A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Antimicrobial isothiocyanates from the seeds of Moringa oleifera Lam.
January 2012, Zeitschrift fur Naturforschung. C, Journal of biosciences,
A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Phytochemistry and Pharmacology of Moringa oleifera Lam.
September 2017, Journal of pharmacopuncture,
A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Moringa (Moringa oleifera Lam.) polysaccharides: Extraction, characterization, bioactivities, and industrial application.
June 2022, International journal of biological macromolecules,
A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Some pharmacognostical characteristics of moringa oleifera lam. Leaves.
April 1996, Ancient science of life,
A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Nutraceutical or Pharmacological Potential of Moringa oleifera Lam.
March 2018, Nutrients,
A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Moringa oleifera (Lam.): a natural remedy for ageing?
December 2021, Natural product research,
A P Guevara, and C Vargas, and H Sakurai, and Y Fujiwara, and K Hashimoto, and T Maoka, and M Kozuka, and Y Ito, and H Tokuda, and H Nishino
Isolation and characterization of a flocculating protein from Moringa oleifera Lam.
April 1995, Biochimica et biophysica acta,
Copied contents to your clipboard!